Products
By Team
Sales
Multithread effectively and personalize outreach to convert deals faster
Social Media Marketing
Elevate social presence and drive business growth from social media
RevOps
Identify and prioritize high-intent leads, and improve sales effectiveness
Events & Field Marketing
Find and connect with ICP attendees, and improve event outcomes
Resources
.png)
.png)
Myotonic Dystrophy Foundation
What Does Myotonic Dystrophy Foundation Do?
Avidity Biosciences, Inc. is a biopharmaceutical company committed to revolutionizing the treatment of diseases previously untreatable with RNA therapeutics. They are pioneering a new class of medicines called Antibody Oligonucleotide Conjugates (AOCs™), designed to combine the specificity of monoclonal antibodies with the precision of oligonucleotide therapies to target the root cause of diseases. Avidity's initial focus is on rare muscle disorders, with lead programs targeting Myotonic Dystrophy Type 1 (DM1), Duchenne Muscular Dystrophy (DMD), and Facioscapulohumeral Muscular Dystrophy (FSHD).
Where Is Myotonic Dystrophy Foundation's Headquarters?
HQ Function
The headquarters serves as the central hub for research and development, corporate operations, and strategic management.
Notable Features:
State-of-the-art laboratory facilities for RNA therapeutic research and development. Proximity to other leading research institutions and biotech companies.
Work Culture:
A dynamic, innovative, and collaborative environment focused on scientific excellence and patient impact. Emphasis on teamwork and a mission-driven approach to tackle challenging diseases.
HQ Significance:
The La Jolla headquarters is critical for Avidity's cutting-edge research in AOC technology and its efforts to advance its pipeline of novel therapeutics.
Values Reflected in HQ: The headquarters likely reflects Avidity's commitment to innovation, scientific rigor, and its mission to deliver transformative medicines to patients.
Location:
While Avidity Biosciences is headquartered in the United States, its impact is global. The company conducts clinical trials in multiple countries to evaluate its novel RNA therapeutics for rare diseases. Their research and collaborations may also extend internationally to advance the science of Antibody Oligonucleotide Conjugates (AOCs™) and address unmet medical needs worldwide. Regulatory interactions and patient advocacy efforts also have a global dimension as they seek to bring their therapies to patients around the world.
Street Address:
10975 North Torrey Pines Road, Suite 150
City:
La Jolla
State/Province:
CA
Country:
USA
Where Else Does Myotonic Dystrophy Foundation Operate Around the World?
San Diego, CA, USA
Address: 10931 North Torrey Pines Road, La Jolla, CA 92037 (Additional Facility)
To accommodate the expansion of R&D teams and capabilities within the San Diego biotech ecosystem, facilitating close collaboration with the main headquarters.
Boston, MA, USA
Address: [Specific address not publicly detailed, general location Boston, MA]
To enhance presence and operational capabilities in another key U.S. biotech cluster, facilitating engagement with partners, investigators, and talent in the region.
Buying Intent Signals for Myotonic Dystrophy Foundation
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Who's Leading Myotonic Dystrophy Foundation? Meet the Executive Team
As of April 2025, Myotonic Dystrophy Foundation' leadership includes:
Who's Investing in Myotonic Dystrophy Foundation?
Myotonic Dystrophy Foundation has been backed by several prominent investors over the years, including:
What Leadership Changes Has Myotonic Dystrophy Foundation Seen Recently?
Avidity Biosciences has seen some key executive transitions and promotions in the last 12 months, strengthening its leadership team as it advances its clinical programs.
Departures
New Appointments:
What Technology (Tech Stack) Is Used byMyotonic Dystrophy Foundation?
Discover the tools Myotonic Dystrophy Foundation uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Myotonic Dystrophy Foundation Email Formats and Examples
Common email formats for companies like Avidity Biosciences typically include first initial + last name or first name.last name @ [companydomain.com]. The exact format can vary.
A likely Avidity Biosciences email format is [firstinitial][lastname]@aviditybiosciences.com or [firstname].[lastname]@aviditybiosciences.com
Format
jdoe@aviditybiosciences.com or jane.doe@aviditybiosciences.com
Example
80%
Success rate
What's the Latest News About Myotonic Dystrophy Foundation?
Avidity Biosciences Press Release • May 9, 2024
Avidity Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
Avidity Biosciences announced its financial results for Q1 2024, highlighting progress in its clinical programs for DM1, DMD, and FSHD, including ongoing patient dosing and data readouts expected....more
Avidity Biosciences Press Release • April 2, 2024
Avidity Announces Positive Long-term AOC 1001 Data from MARINA-OLE™ Trial Showing Reversal of Disease Progression in Adults with Myotonic Dystrophy Type 1 (DM1) on Multiple Endpoints
Avidity reported compelling long-term data from the MARINA-OLE™ trial of AOC 1001, demonstrating reversal of disease progression in DM1 patients across several key endpoints including vHOT, muscle strength, and mobility....more
Avidity Biosciences Press Release • February 20, 2024
Avidity Biosciences Announces CSO Transition Plan and Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights
Avidity announced that W. Michael Flanagan, Ph.D., Chief Scientific Officer, would transition to an advisory role and LaRisa Lucero, Ph.D., was promoted to CSO. The company also reported its Q4 and full-year 2023 financials....more
Highperformr's free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Myotonic Dystrophy Foundation, are just a search away.